Litigation Details for Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC (D. Del. 2018)
✉ Email this page to a colleague
Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC (D. Del. 2018)
| Docket | ⤷ Subscribe | Date Filed | 2018-09-20 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,010,533; 8,609,707; 9,265,831; 9,572,796; 9,572,797 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC
The small molecule drugs covered by the patents cited in this case are ⤷ Subscribe and ⤷ Subscribe .
Details for Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-09-20 | 1 | (“the ’796 patent”); 9,572,797 (“the ’797 patent”); and 10,010,533 (“the ’533 patent”) (collectively,…COUNT V – INFRINGEMENT OF U.S. PATENT NO. 10,010,533 UNDER 35 U.S.C. § 271(e)(2)… INFRINGEMENT OF U.S. PATENT NO. 10,010,533 119. Eagle incorporates…of the ’707 patent, the ’831 patent, the ’796 patent, the ’797 patent, and the ’533 patent. …Plaintiff’s U.S. Patent Nos. 8,609,707 (“the ’707 patent”); 9,265,831 (“the ’831 patent”); 9,572,796 (“ | External link to document | |
| 2018-09-20 | 3 | ,831 B2; US 9,572,796 B2; US 9,572,797 B2; US 10,010,533 B2. (crb) (Entered: 09/21/2018) 20 September… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,609,707 B2…20 September 2018 1:18-cv-01459 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
